AAV Quality
Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.
Rentschler Biopharma SE
PAO-11-24-CL-06Dec 02, 2024
PPQ
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
Jessica Feldman, Ph.D.; Henning Gerschewski
Rentschler Biopharma SE
PAO-10-24-CL-12Dec 02, 2024
Expansion
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Benedikt von Braunmühl; Tom Roberts
Rentschler Biopharma SE
PAO-09-24-CL-05Sep 09, 2024
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01Sep 15, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02Sep 15, 2023
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01Jun 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01Jun 24, 2022
Strategic Alliance
Rentschler Biopharma and Vetter Unveil Xpert Alliance
Rentschler Biopharma SE
PR-M03-22-14Mar 29, 2022
Biopharmaceutical Manufacturing
Investing and Expanding for High-Quality Biopharmaceuticals
Rentschler Biopharma SE
PAO-02-22-R250-19Feb 24, 2022
Integrated Services
Collaborating Strategically and Leveraging Innovation to Drive Success
Federico Pollano
Rentschler Biopharma SE
PAO-10-21-CL-18Nov 22, 2021
Collaboration
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
Peter Soelkner
Vetter Pharma International GmbH
PAO-06-21-CL-02-954Jun 09, 2021
Vetter and Rentschler Biopharma Further Strengthen Their Strategic Alliance
Rentschler Biopharma SE
PR-M04-21-028Apr 28, 2021
Cover Story
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
Rentschler Biopharma SE
PAP-Q4-20-CL-028Dec 09, 2020
Industry Leader
Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing
Frank Mathias, Ph.D.
Rentschler Biopharma SE
PAP-Q4-20-CL-023Dec 09, 2020
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
Peter Soelkner; Frank Mathias, Ph.D.
Vetter Pharma International GmbH
PAP-Q3-20-CL-028Sep 29, 2020
Collaboration
The Key to Tackling Drug Development Complexity: Collaboration
Rentschler Biopharma SE
PR-M07-20-NI-005Jul 07, 2020
Collaboration
Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility
Rentschler Biopharma SE
PR-M05-20-NI-038May 27, 2020
CDMO Leadership
A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership
Frank Mathias, Ph.D.
Rentschler Biopharma SE
PAP-Q1-20-CL-003Mar 19, 2020
Innovation
Driving Innovation to Support Strategic Client Partnerships
Federico Pollano
Rentschler Biopharma SE
PAP-Q2-2019-CL-028May 24, 2019
Benefitting U.S. Clients
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position
Federico Pollano
Rentschler Biopharma SE
PAP-Q1-2019-CL-033Mar 12, 2019